First Lawsuits In The YAZ / Yasmin / Gianvi / Ocella / Beyaz / Safyral Drug Injury Litigation Were Filed In 2009, With Thousands Of Cases Still Pending
The most recent Bayer information about the YAZ / Yasmin drug injury litigation comes from the Bayer Interim Report for the Second Quarter of 2015 (at pg. 54 of PDF):
Yasmin™/YAZ™: As of July 17, 2015, the number of claimants in the pending lawsuits and claims in the United States totaled about 4,000 (excluding claims already settled). Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States.
As of July 17, 2015, Bayer had reached agreements, without admission of liability, to settle approximately 9,900 claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) for a total amount of about US$1.97 billion. Bayer will continue to consider the option of settling such claims after a case-specific analysis of medical records. At present, about 590 such claims are under review.... As of July 17, 2015, about 1,200 of the 4,000 above-mentioned claimants alleged arterial thromboembolic injuries.
This YAZ / Yasmin litigation status information was published by Bayer on July 29, 2015.
We expect to find updated settlement numbers in the Bayer Interim Report for the Third Quarter of 2015, which is currently scheduled to be published on October 29, 2015 according to the Bayer Quarterly Reports page of the company's website for investors.
To put into context the latest YAZ / Yasmin lawsuits and settlement numbers from Bayer, we refer back to this article, "According To Bayer, In April 2015 There Were 400 Fewer YAZ / Yasmin Lawsuits Pending, 100 More Settlements, And 500 Cases Just Seem To Vanish From Their Radar", which we posted on June 22, 2015. From that earlier article we get this comparative YAZ / Yasmin litigation information:
• As of April 20, 2015, the number of claimants in the pending lawsuits and claims in the United States totaled about 4,600 (excluding claims already settled).
• As of April 20, 2015, Bayer had reached agreements, without admission of liability, to settle approximately 9,600 claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) for a total amount of about US$1.92 billion.
• At present, about 1,000 such claims are under review.
We will continue to report periodically on the YAZ / Yasmin / Gianvi / Ocella / Beyaz / Safyral litigation, as we have been doing since 2009 when the first lawsuits against Bayer were filed.